Elevated CA 19-9 caused by Hashimoto's thyroiditis: Review of the benign causes of increased CA 19-9 level

Digestive Diseases and Sciences

Volumn 50, Issue 4, 2005, Pages 694-695

  Parra, Javier L ^a   Kaplan, Steven ^a   Barkin, Jamie S ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Colon cancer; Elevation of CA 19 9 levels; Hashimoto's thyroititis; Pancreas

Indexed keywords

CA 19-9 ANTIGEN; TUMOR MARKER;

AGED; BREAST TUMOR; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; FEMALE; FOLLOW UP; HASHIMOTO DISEASE; HISTOPATHOLOGY; HUMAN; KIDNEY CYST; LABORATORY TEST; PRIORITY JOURNAL; RECTUM ADENOMA; REVIEW; TREATMENT OUTCOME; UTERUS MYOMA; UTERUS TUMOR;

AGED; AGED, 80 AND OVER; CA-19-9 ANTIGEN; FEMALE; HUMANS; THYROIDECTOMY; THYROIDITIS, AUTOIMMUNE;

EID: 17644376856     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-2559-z     Document Type: Review

References (4)

1. Postner MR, Mayer RJ: The use of serologic tumor markers in gastrointestinal malignancies. Hemarol Oncol Clin North Am 8:533-553, 1994
2. Bast, RC Jr, Ravdin P, Hayes, DF, et al.: Update of recommendations for the use of tumor markers in breast and colorectal cancer: Clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 15:1865-1878, 2001
3. Safadi R, Ligumsky M, Goldin E, Ilan Y, Haviv YS, Nusair S: Increased serum CA 19-9 antibodies in Sjogren's syndrome. Postgrad Med J 74(875):543-544, 1998
4. Schmid KW, Ofner C, Ramsauer T, Hittmair A, Totsch M, Ladurner D, Bocker W: CA 19-9 expression in subacute (de Quervain's) thyroiditis: An immunohistochemical study. Mod Pathol 5(3):268-272, 1992